BIOMAT Database Logo BIOMAT Database Logo

New derivatives of quinazoline and 1, 2-dihydroquinazoline n3-oxide with expected antitumor activity. 2004

Elzbieta Mikiciuk-Olasik, and Katarzyna Baszczak-Swiatkiewiz, and Elzbieta Zurek, and Urszula Krajewska, and Marek Rózalski, and Rafał Kruszyński, and Tadeusz J Bartczak
Department of Pharmaceutical Chemistry and Drug Analysis, Medical University, Łódź, Poland. eolasik@farm.pharm.am.lodz.pl

Some derivatives of quinazoline and 1, 2-dihydroquinazoline N(3)-oxide were synthesised and their cytotoxic activities against human leukaemia HL-60 cells under hypoxic and aerobic conditions were tested and compared to tirapazamine as the reference compound. Compound 8 showed 5-fold higher toxicity under hypoxic conditions than in normal oxygen atmosphere. The structure of quinazoline derivatives was established by X-ray crystal structure analysis.

UI MeSH Term Description Entries
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015687 Cell Hypoxia A condition of decreased oxygen content at the cellular level. Anoxia, Cellular,Cell Anoxia,Hypoxia, Cellular,Anoxia, Cell,Anoxias, Cell,Anoxias, Cellular,Cell Anoxias,Cell Hypoxias,Cellular Anoxia,Cellular Anoxias,Cellular Hypoxia,Cellular Hypoxias,Hypoxia, Cell,Hypoxias, Cell,Hypoxias, Cellular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Elzbieta Mikiciuk-Olasik, and Katarzyna Baszczak-Swiatkiewiz, and Elzbieta Zurek, and Urszula Krajewska, and Marek Rózalski, and Rafał Kruszyński, and Tadeusz J Bartczak
Design, synthesis and antitumor activity of 2-substituted quinazoline-4-amine derivatives.
March 2024, Bioorganic & medicinal chemistry,
Elzbieta Mikiciuk-Olasik, and Katarzyna Baszczak-Swiatkiewiz, and Elzbieta Zurek, and Urszula Krajewska, and Marek Rózalski, and Rafał Kruszyński, and Tadeusz J Bartczak
Design, Synthesis, and Antitumor Activity of Novel Quinazoline Derivatives.
September 2017, Molecules (Basel, Switzerland),
Elzbieta Mikiciuk-Olasik, and Katarzyna Baszczak-Swiatkiewiz, and Elzbieta Zurek, and Urszula Krajewska, and Marek Rózalski, and Rafał Kruszyński, and Tadeusz J Bartczak
[Pyridyl derivatives of quinazoline-4 with expected pharmacological effect].
January 1970, Acta poloniae pharmaceutica,
Elzbieta Mikiciuk-Olasik, and Katarzyna Baszczak-Swiatkiewiz, and Elzbieta Zurek, and Urszula Krajewska, and Marek Rózalski, and Rafał Kruszyński, and Tadeusz J Bartczak
Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety.
August 2012, European journal of medicinal chemistry,
Elzbieta Mikiciuk-Olasik, and Katarzyna Baszczak-Swiatkiewiz, and Elzbieta Zurek, and Urszula Krajewska, and Marek Rózalski, and Rafał Kruszyński, and Tadeusz J Bartczak
Synthesis and anticancer activity of new quinazoline derivatives.
November 2017, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
Elzbieta Mikiciuk-Olasik, and Katarzyna Baszczak-Swiatkiewiz, and Elzbieta Zurek, and Urszula Krajewska, and Marek Rózalski, and Rafał Kruszyński, and Tadeusz J Bartczak
[New coumarin derivatives with expected biological activity].
January 1984, Acta poloniae pharmaceutica,
Elzbieta Mikiciuk-Olasik, and Katarzyna Baszczak-Swiatkiewiz, and Elzbieta Zurek, and Urszula Krajewska, and Marek Rózalski, and Rafał Kruszyński, and Tadeusz J Bartczak
Synthesis of novel chromene derivatives of expected antitumor activity.
January 2013, European journal of medicinal chemistry,
Elzbieta Mikiciuk-Olasik, and Katarzyna Baszczak-Swiatkiewiz, and Elzbieta Zurek, and Urszula Krajewska, and Marek Rózalski, and Rafał Kruszyński, and Tadeusz J Bartczak
Novel quinazoline derivatives exhibit antitumor activity by inhibiting JAK2/STAT3.
October 2015, Oncology reports,
Elzbieta Mikiciuk-Olasik, and Katarzyna Baszczak-Swiatkiewiz, and Elzbieta Zurek, and Urszula Krajewska, and Marek Rózalski, and Rafał Kruszyński, and Tadeusz J Bartczak
Discovery of quinazoline-2,4(1H,3H)-dione derivatives as novel PARP-1/2 inhibitors: design, synthesis and their antitumor activity.
May 2018, Organic & biomolecular chemistry,
Elzbieta Mikiciuk-Olasik, and Katarzyna Baszczak-Swiatkiewiz, and Elzbieta Zurek, and Urszula Krajewska, and Marek Rózalski, and Rafał Kruszyński, and Tadeusz J Bartczak
Synthesis and antitumor activity evaluation of quinazoline derivatives bearing piperazine-1-carbodithioate moiety at C4-position.
October 2016, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!